This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Cytheris, Sanofi-Synthelabo. Active years: 2004-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boulogne Billancourt, FR (2009)
- Boulogne, FR (2004 - 2012)
Company Filing History:
Years Active: 2004-2012
Title: Michel Christian Morre: Innovator in Interleukin-7 Research
Introduction
Michel Christian Morre is a notable inventor based in Boulogne Billancourt, France. He has made significant contributions to the field of biotechnology, particularly in the development of interleukin-7 polypeptides. With a total of 5 patents to his name, Morre's work has the potential to impact therapeutic treatments for various mammalian subjects, including humans.
Latest Patents
Morre's latest patents focus on hyperglycosylated mammalian IL-7 IgG conjugate compositions. These inventions relate to new and improved interleukin-7 polypeptides, as well as their preparation and uses. The patents detail hyperglycosylated IL-7 polypeptides that exhibit enhanced properties, along with their manufacture and therapeutic applications. Additionally, the inventions disclose novel IL-7 polypeptides with modified amino acid sequences that contain artificially created glycosylation sites. Corresponding nucleic acid molecules, vectors, and recombinant host cells are also part of these innovations. The applications of these polypeptides, cells, or nucleic acids are aimed at curative or preventive treatments for mammalian subjects.
Career Highlights
Throughout his career, Michel Christian Morre has worked with prominent companies in the biotechnology sector, including Cytheris and Sanofi-Synthelabo. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.
Collaborations
Morre has collaborated with several professionals in his field, including Brigitte Assouline and Anne Gregoire. These collaborations have likely enriched his research and development efforts.
Conclusion
Michel Christian Morre is a distinguished inventor whose work in interleukin-7 research has the potential to advance therapeutic treatments. His contributions to biotechnology are noteworthy, and his patents reflect a commitment to innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile